Key facts
- Unitree priced its Shanghai IPO at 150.8 yuan per share.
- Unitree aims to raise 6.1 billion yuan ($904 million) through its IPO.
- Unitree will be the first mainland-listed humanoid robot manufacturer.
- China is reportedly fast-tracking the development of rapid-implant brain-computer interfaces (BCIs).
- The goal for BCI implantation procedures is to be completed in under 10 minutes.
- This advancement in BCIs aims to overcome current limitations in implantation time and complexity.
Chinese robot maker Unitree has set its initial public offering (IPO) price at 150.8 yuan per share on the Shanghai Stock Exchange. The company aims to raise approximately 6.1 billion yuan, which is equivalent to $904 million. This pricing makes Unitree poised to become the first mainland-listed manufacturer of humanoid robots. The IPO reflects a broader trend of Chinese companies seeking public listings amid robust investor enthusiasm and substantial government backing for the robotics industry.